NCT03287024View on ClinicalTrials.gov

BeGrow Study to Treat Pulmonary Artery (PA) Stenosis in Newborns and Infants

NAActive, not recruitingINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

March 1, 2018

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2027

Conditions
Pulmonary Artery Stenosis
Interventions
DEVICE

BeGrow Stent System

All enrolled subjects will undergo primary stenting of the target lesion by placement of the BeGrow Stent System

Trial Locations (3)

1090

Medizinische Universität Wien, AKH Wien, Abteilung für Pädiatrische Kardiologie, Vienna

8032

Universitäts-Kinderspital Zürich, Zurich

11000

University Children's Hospital, Center for Pediatrics - Department of Cardiology, Belgrade

All Listed Sponsors
lead

Bentley InnoMed GmbH

INDUSTRY

NCT03287024 - BeGrow Study to Treat Pulmonary Artery (PA) Stenosis in Newborns and Infants | Biotech Hunter | Biotech Hunter